Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07571590
Effectiveness of a Self-Efficacy Based Educational Program on Glycemic Self-Monitoring, Diabetes Self-Management Knowledge, and Health-Related Quality of Life Among Adults With Type 2 Diabetes MellitusJerash Private UniversityNot Yet RecruitingNot Applicable
NCT07571590Not Yet Recruiting
Not Applicable
Effectiveness of a Self-Efficacy Based Educational Program on Glycemic Self-Moni...Jerash Private University
NCT07569471
REFLECT: A Novel Group-Based Compassion-Focussed Cognitive Behavioural Approach to Core Beliefs in PsychosisUniversity of TorontoRecruitingNot Applicable
NCT07569471Recruiting
Not Applicable
REFLECT: A Novel Group-Based Compassion-Focussed Cognitive Behavioural Approach...University of Toronto
NCT07571824
A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy SubjectsCorium Innovations, Inc.RecruitingPhase 1
NCT07571824Recruiting
Phase 1
A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy...Corium Innovations, Inc.
NCT07568561
Maternal Methyl-Nutrient Status and Infant Neurodevelopment StudyFar Eastern Memorial HospitalNot Yet Recruiting
NCT07568561Not Yet Recruiting
—
Maternal Methyl-Nutrient Status and Infant Neurodevelopment StudyFar Eastern Memorial Hosp...
NCT07570251
Evaluation of Cognitive Education Activities in Breast Cancer Patients Receiving ChemotherapySaglik Bilimleri UniversitesiCompletedNot Applicable
NCT07570251Completed
Not Applicable
Evaluation of Cognitive Education Activities in Breast Cancer Patients Receiving...Saglik Bilimleri Universi...
NCT07570589
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)Centre Hospitalier Universitaire de NiceNot Yet Recruiting
NCT07570589Not Yet Recruiting
—
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evol...Centre Hospitalier Univer...
NCT07569926
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical RecurrenceBlue Earth DiagnosticsNot Yet RecruitingPhase 4
NCT07569926Not Yet Recruiting
Phase 4
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Managemen...Blue Earth Diagnostics
NCT07569939
Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/or Viral TonsillitisUniversity Hospital, Clermont-FerrandNot Yet RecruitingNot Applicable
NCT07569939Not Yet Recruiting
Not Applicable
Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/o...University Hospital, Cler...
NCT07568821
Effectiveness of VR Rehabilitation for People With Asymmetrical Gait PatternsUniversity of RzeszowNot Yet RecruitingNot Applicable
NCT07568821Not Yet Recruiting
Not Applicable
Effectiveness of VR Rehabilitation for People With Asymmetrical Gait PatternsUniversity of Rzeszow
NCT07568704
Image Evaluation of Intalight Dream OCTA Scans With Optos FA & ICGA ImagesIntalight, IncRecruiting
NCT07568704Recruiting
—
Image Evaluation of Intalight Dream OCTA Scans With Optos FA & ICGA ImagesIntalight, Inc
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07569120
In Vivo Noradrenergic System and AgingHospices Civils de LyonNot Yet RecruitingNot Applicable
NCT07569120Not Yet Recruiting
Not Applicable
In Vivo Noradrenergic System and AgingHospices Civils de Lyon
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07570368
Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to Enhance Neoadjuvant Chemotherapy Response in Locally Advanced Breast CancerUniversitas AirlanggaNot Yet RecruitingNot Applicable
NCT07570368Not Yet Recruiting
Not Applicable
Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to E...Universitas Airlangga
NCT07570069
Effects of Efavirenz on the Pharmacokinetics of Suzetrigine in Healthy ParticipantsVertex Pharmaceuticals IncorporatedNot Yet RecruitingPhase 1
NCT07570069Not Yet Recruiting
Phase 1
Effects of Efavirenz on the Pharmacokinetics of Suzetrigine in Healthy Participa...Vertex Pharmaceuticals In...
NCT07569055
Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell TransplantationFirst Affiliated Hospital of Guangxi Medical UniversityRecruiting
NCT07569055Recruiting
—
Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoie...First Affiliated Hospital...
NCT07569042
A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed GlioblastomaNovelwise Pharmaceutical CorporationRecruitingPhase 1
NCT07569042Recruiting
Phase 1
A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Ne...Novelwise Pharmaceutical...
NCT07569081
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) SyndromeGlaxoSmithKlineNot Yet RecruitingPhase 2
NCT07569081Not Yet Recruiting
Phase 2
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With V...GlaxoSmithKline
NCT07570511
Point of Care Testing INR in Antiphospholipid SyndromeCentral Hospital, Nancy, FranceNot Yet RecruitingNot Applicable
NCT07570511Not Yet Recruiting
Not Applicable
Point of Care Testing INR in Antiphospholipid SyndromeCentral Hospital, Nancy,...
Result Breakdown
Not yet recruiting11 (55%)
Recruiting7 (35%)
Completed1 (5%)
Active, not recruiting1 (5%)
not_applicable9 (45%)
Not Specified5 (25%)
Phase 13 (15%)
Phase 22 (10%)
Phase 41 (5%)